Treatment of meningioma cells with 5 nM siRNA decreased TGM2 mRNA expression by 80–90% 2 days after transfection by quantitative RT-PCR and resulted in a 30% reduction in cell survival (Figure 3B). This evidence concerns the gene TGM2 and meningioma.